Title : First-in-Human Studies for a Selective RET Tyrosine Kinase Inhibitor, GSK3179106, to Investigate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers.

Pub. Date : 2019 Feb

PMID : 30277655






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 First-in-Human Studies for a Selective RET Tyrosine Kinase Inhibitor, GSK3179106, to Investigate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers. GSK3179106 ret proto-oncogene Homo sapiens
2 GSK3179106 is a RET kinase inhibitor that was administered in double-blind, randomized, placebo-controlled single-dose and repeat-dose studies in healthy subjects to investigate its pharmacokinetics and safety/tolerability. GSK3179106 ret proto-oncogene Homo sapiens